8-38414279-C-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_023110.3(FGFR1):c.2059G>A(p.Gly687Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G687?) has been classified as Pathogenic.
Frequency
Consequence
NM_023110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFR1 | NM_023110.3 | c.2059G>A | p.Gly687Arg | missense_variant | 16/18 | ENST00000447712.7 | NP_075598.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR1 | ENST00000447712.7 | c.2059G>A | p.Gly687Arg | missense_variant | 16/18 | 1 | NM_023110.3 | ENSP00000400162.2 | ||
FGFR1 | ENST00000397091.9 | c.2053G>A | p.Gly685Arg | missense_variant | 16/18 | 1 | ENSP00000380280.5 | |||
FGFR1 | ENST00000397108.8 | c.2053G>A | p.Gly685Arg | missense_variant | 17/19 | 1 | ENSP00000380297.4 | |||
FGFR1 | ENST00000397113.6 | c.2053G>A | p.Gly685Arg | missense_variant | 16/18 | 2 | ENSP00000380302.2 | |||
FGFR1 | ENST00000356207.9 | c.1792G>A | p.Gly598Arg | missense_variant | 15/17 | 1 | ENSP00000348537.5 | |||
FGFR1 | ENST00000397103.5 | c.1792G>A | p.Gly598Arg | missense_variant | 14/16 | 5 | ENSP00000380292.1 | |||
FGFR1 | ENST00000326324.10 | c.1786G>A | p.Gly596Arg | missense_variant | 15/17 | 1 | ENSP00000327229.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 2 with or without anosmia Pathogenic:2
Pathogenic, criteria provided, single submitter | research | Reproductive Endocrine Unit, Massachusetts General Hospital | May 04, 2023 | The variant has been classified as P3b based on the variant meeting the following ACMG Criteria: PM2,PP3,PM1,PP1,PP2,PP4. - |
Pathogenic, no assertion criteria provided | research | Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | - | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | FGFR1: PM1, PM2, PS4:Moderate, PP3, PP4, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2022 | Published functional studies demonstrate this variant damages normal FGFR1 function (Wang et al., 2020); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31067328, 32666525, 23329143, 26207952, 23643382, 25636053, 30098700, 33548149, 25226293, 30430143, 27502037, 15845591) - |
Hypogonadotropic hypogonadism 7 with or without anosmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | case-control | Chan Lab, Boston Children's Hospital | Nov 01, 2014 | - - |
FGFR1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2023 | The FGFR1 c.2059G>A variant is predicted to result in the amino acid substitution p.Gly687Arg. This variant (also described as p.Gly685Arg) has been reported in multiple unrelated individuals with hypogonadotropic hypogonadism or Kallmann syndrome and segregated with disease in several families (Sato. 2005. PubMed ID: 15845591; Table S3, Miraoui. 2013. PubMed ID: 23643382; Choi. 2015. PubMed ID: 26207952; Quaynor. 2016. PubMed ID: 27502037; Table S3, Zhou. 2018. PubMed ID: 30098700; Wang. 2020. PubMed ID: 32666525; Nie. 2021. PubMed ID: 33548149). This variant impaired tyrosine kinase activity in an in vitro functional assay (Wang. 2020. PubMed ID: 32666525). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In ClinVar this variant is listed as likely pathogenic and pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/180160/). This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at